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Abstract
Background: A significant and growing number of clinical research studies
conducted in Intensive Care Units (ICUs) today have some genetic and
genomics component. Surrogates approached to authorize participation in
clinical research for a loved-one in the ICU may not be prepared to make
informed decisions. An author-developed model of stewardship of genetic and
genomics research was used as a framework for this study. In addition, the
literature review, prepared for publication, identified surrogate education as an
important factor in surrogate understanding of the process of informed consent
and knowledge of genetic and genomics research. Purpose: The purpose of this
investigation was to examine the effect of an author-developed educational
program, the Interactive Computerized Information for Surrogates (ICIS) ICU
Education Program in assisting surrogates to (1) increase their understanding of
the process of informed consent and (2) increase their knowledge of genetic and
genomics research. Methods: Visitors in two ICU waiting rooms (potential
surrogates) in a large metropolitan medical center were randomly assigned to an
experimental group (n = 64) who received the ICIS ICU Education Program plus
the Sample Consent Form and the control group (n = 69) who received the
Sample Consent Form alone. Both groups completed the author-developed
Posttest Instrument (α = .730). Results: Overall, understanding the process of
informed consent was significantly higher (p = .05) in the experimental versus the
control group (Wilcoxon W = 3346; p = 0.000). In addition, knowledge of genetics
and genomics research was significantly higher (p = .05) in the experimental
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versus the control group (Wilcoxon W 3853.5, p = 0.000). The ICIS ICU
Education Program plus the Sample Consent Form was superior to the Sample
Consent Form alone in 9 of the 14 items on the Posttest Instrument in increasing
the understanding of the process of informed consent and in increasing the
knowledge of genetic and genomics research in surrogates. Based on study
findings, the ICIS ICU Education Program was a feasible, useful, and effective
program when used to educate surrogates about informed consent and genetic
and genomics research in the ICU. A recommendation was made to administer
the ICIS ICU Education Program to surrogates prior to asking them to sign the
Sample Consent Form. This research has the potential to contribute to the
literature regarding the preparation of surrogate consenters for research in the
ICU, increase participation in clinical research through education, augment the
NIH goal of informing the public about genomics, and provide an interactive
educational program that is adaptable to many ICU environments.
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CHAPTER I
Introduction
In this chapter the problem, the problem statement, the purpose, and the
significance surrounding the issues of surrogate informed consent for genetic
and genomics research conducted in the intensive care unit (ICU) are discussed.
In addition, associated assumptions and hypotheses are presented.
Problem
The U.S. Centers for Disease Control and Prevention state that there is
some genetic component influencing most disease processes (Beery & Hern,
2004). Understanding the etiology of illness, predicting therapeutic effects or
adverse medication reactions, and developing testing and treatment innovations
constitutes the promise of genomics research and will transform the provision of
health care (Beery & Hern, 2004; Collins, Green, Guttmacher, & Guyer, 2003).
This understanding of genetics and genomics is critical to the clinical application
of new knowledge of health and disease gleaned from research such as the
Human Genome Project. Since the inception of the Human Genome Project,
there has been an ongoing debate about the ethical, legal, and social
implications (ELSI) of genetic and genomics research. Fundamental ELSI
considerations such as privacy, confidentiality, insurability, and discrimination
impact stakeholders involved in genetic and genomics research. In fact, project
developers anticipated the enormity of ELSI to the Human Genome Project and
designated approximately 3% – 5% of the total NIH Human Genome Project
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funding package to study its impact on individuals, families, community
organizations, and institutions (Ojha & Thertulien, 2005).
Specific Clinical Problem
Critically ill ICU patients often are unable to consent to participate in genetic
and genomics research due to cognitive impairment associated with trauma,
fever, sedation, pain, or shock (Davis, Pohlman, Gehlbach, Kress, McTee,
Herlitz, et al. 2003; Freeman, Kennedy, Coopersmith, Zehnbauer, & Buchman,
2006; Jamerson, Scheibmeir, Bott, Crighton, Hinton, & Cobb, 1996). Therefore,
surrogate, or proxy, consent may be desired in an emergent situation for which
study enrollment cannot be delayed. Surrogate informed consent is a critical
component of genomics research in the ICU. Yet, surrogates are asked to make
complex research participation decisions for their loved-ones in the ICU; many of
whom have an insufficient understanding of the process of informed consent and
insufficient knowledge of genetics and genomics research (Davis et al. 2003;
Jamerson et al. 1996).
Problem Statement
There is a paucity of research about surrogate consenter’s understanding of
the process of informed consent and knowledge of genetic and genomics
research in the ICU. Yet, surrogate decision makers are called upon to give their
consent for loved-ones to participate in genomics research with its ELSI
considerations. Little is known about the surrogate decision maker experience as
it relates to understanding the information disclosed in the process of informed
consent or knowledge of genomics research. Thus, surrogates approached to
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authorize participation for a loved-one in genomics research in the ICU may be
ill-prepared to make these decisions. In fact, there are no published papers
focusing specifically on an intervention to facilitate surrogate informed consent
for genetic or genomics research in the ICU. An education intervention may have
the potential to enhance the understanding of the process of informed consent
and knowledge of genetic and genomics research in surrogates in the ICU.
Purpose
The purpose of this investigation is to examine the effectiveness of an
educational program, the Interactive Computerized Information for Surrogates
ICU Education Program (ICIS), in assisting surrogates to (1) increase
understanding of the process of informed consent and (2) increase knowledge of
genetic and genomics research.
Significance of the ICIS ICU Education Program
The ICIS ICU Education Program was developed by the author to facilitate
the process of informed consent using technology to complement the information
provided on a sample consent form. The ICIS ICU Education Program is an
interactive computerized program designed to inform and instruct surrogates in
the ICU about the process of informed consent and genetic and genomics
research using a straightforward, individually paced, and comprehensive
approach. The ICIS ICU Education Program also provides a framework with
which to measure understanding of the process of informed consent and
knowledge of genetic and genomics research.
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This project has the potential to (a) contribute to the literature regarding the
educational preparation of surrogate consenters for research in the ICU, (b)
support institutional mandates to ensure informed consent, (c) increase
participation in clinical research through education, (d) augment the National
Institutes of Health (NIH) goal of informing the public about genetic and
genomics, and (e) provide an expandable, interactive educational program that is
adaptable to many ICU environments.
Significance of the Literature Review Regarding Informed Consent and
Genetic and Genomics Research in the ICU
A literature review was conducted by the author for publication to add to
nursing’s knowledge base and facilitate evidence based practice for attaining
surrogate informed consent in genetic and genomics research in the ICU. The
purpose of this paper was to provide a systematic review of the literature
examining the challenges and strategies surrounding the solicitation of surrogate
consent for genetic and genomics research in the ICU. Overall, there are few
well-controlled studies and still fewer studies specifically focused on genomics
research in the ICU. Yet a major theme in this literature is the role of the health
care professional in guiding the surrogate through the process of informed
consent rather than simply witnessing a signature. The process of informed
consent requires explicit strategies to effectively approach the surrogate, educate
the surrogate, and assure that informed consent has been attained.
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Significance of the Stewardship Model of Genetic and Genomics Research
A stewardship model of genetic and genomics research was developed by
the author to facilitate theory generation and evidence based practice regarding
the ethical conduct of the process of informed consent regarding genetic and
genomics research. Stewardship of genetic and genomics research is depicted
as balancing on a scale between the mandate to conduct essential genetic and
genomics research and the preservation and protection of human rights.
Associated Assumptions
The first assumption in the current study is that genetic and genomics
information is intensely personal (Knoppers & Chadwick, 1994). Clearly, sensitive
genetic data involving individuals have the potential to be generated, stored, and
distributed swiftly and efficiently once obtained. Thus, preserving the privacy and
confidentiality of genetic information is central to the concept of stewardship as it
relates to genetic information. The second assumption in the current study is that
it is in the public interest to produce and disseminate health research (Pang,
2004). The third assumption is that the surrogate consenter has the same right to
information as does the participant. The fourth assumption is that genetic and
genomics information is different from other research information and requires
special consideration.
Hypotheses
Hypothesis I
Understanding of the process of informed consent will be greater in the
experimental group as compared to the control group.
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Hypothesis II
Knowledge of genetic and genomics research will be greater in the
experimental group as compared to the control group.
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CHAPTER II
Introduction
Chapter II includes theoretical definitions and a review of literature. Two
conceptual models of stewardship of genetic and genomics research are also
presented.
Theoretical Definitions
Genetics and Genomics
Genetics is the branch of biology that studies heredity. Genomics refers to
the study of all the genes in the human genome together, including their
interaction with each other, the environment, and the influence of other
psychosocial and cultural factors (Beery & Hern, 2004).
Informed Consent
Informed consent is the agreement to participate in experimental treatment or
another form of clinical research, with the following stipulations: (a) all information
relevant to the participant’s decision must be disclosed and the participant must
understand the information presented, (b) the authorization of informed consent
is only valid if the participant/surrogate is mentally competent and consent is
given freely and without coercion, and (c) the consent should be given in writing
(Maslin-Prothero, 2003; Declaration of Helsinki, 1983). However, informed
consent is not complete when a signature is obtained. It is a process that
continues throughout the research.
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Stewardship
Stewardship, related to genetic and genomics research reflects the
commitment by all stakeholders, including the researcher and the institution, to
the qualities of ethical research and to responsibility, evidenced by accountability
and trust.
Surrogate
A surrogate may be defined as a stand-in for health care decision making
when the patient is unable to consent for testing, treatment, or research
(Silverman, Luce, Lanken, Morris, Harabin, & Oldmixon et al. 2005).
Understanding the Process of Informed Consent
Understanding the process of informed consent is a cognitive grasp of facts
about participating in clinical research.
Knowledge of Genetics and Genomics Research
Knowledge of genetics and genomics research indicates the ability to
intellectually process critical facts and information about a highly complex
research process.
Review of Literature: Surrogate Consent for Genomics Research in ICU
Genomics refers to the interactive relationship of genes within the genome
and with the environment (Beery & Hern, 2004; Feetham, Thomson, & Hinshaw,
2005; Guttmacher & Collins, 2002; Guttmach & Collins, 2003). In the ICU setting,
circumstances arise where the patient is not able to give informed consent for
genomics research (Chen, Miller, & Rosenstein, 2002; Davis et al. 2003). These
patients often experience cognitive impairment resulting from illness, trauma,
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pain, sedation, or anesthesia (Davis, et al. 2003; Freeman et al. 2006; Jamerson
et al.1996). In such circumstances, surrogates are asked to serve as proxies and
provide informed consent to genomics research on behalf of a loved on in ICU
(American Thoracic Society, 2004; Chen et al. 2002, Davis et al. 2003; Silverman
et al. 2005). Yet, without a basic understanding of genomics, surrogates are illprepared to make the informed decision necessary to consent to genomics
research (Davis et al. 2003; Jamerson et al.1996). Beery & Hern (2004) and
others describe many ELSI considerations of genomics for patient care,
education, and research including psychological effects, privacy, stigmatization,
insurability, and conflicts of interest (American Thoracic Society, 2003; Arnold &
Kellum, 2003; Beery & Hern, 2004; Bigatello, George, & Hurford, 2003; Feetham
et al. 2005; Freeman et al. 2006; Hoedemaekers, Gordijn, & Pijnenburg, 2006;
Hook, DiMagno, & Tefferi, 2004). These implications have been considered such
important issues that the Human Genome Project dedicated 3-5% of its total
budget to the study of ELSI (Collins, et al. 2003; Feetham et al. 2005; Hook et al.
2004; Ojha & Thertulien, 2005).
Despite its growing complexity and significance, little is known about the
surrogate decision-maker’s experience when asked to consent to genomics
research in the ICU or about the surrogate’s ability to understand the information
disclosed in the consent process (American Thoracic Society, 2004; Chen et al.
2002). In addition, surrogates may not know their loved one’s health care wishes.
Further, written policies regarding surrogate consent do not provide step-by-step
guidelines for clinicians and policies vary from state to state (Chen et al. 2002).
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The purpose of this paper is to provide a systematic review of the literature
examining the challenges and strategies surrounding the solicitation of surrogate
consent for genomics research in the ICU. This paper integrates studies and
expert opinion from the areas of medicine, nursing, environmental psychology,
critical care, ethics, genomics, and education.
From the literature review, a three-step process of informed consent
emerged which is used as the framework of this paper: (a) approaching the
surrogate, (b) educating the surrogate, and (c) concluding the process of
informed consent. The literature about approaching the surrogate has five main
themes: surrogate challenges, environment, timing, legal aspects, and
misinformation surrounding genomics research and the process of informed
consent. The literature on educating the surrogate focuses on language and
literacy challenges, teaching the elements of consent, choosing a teaching
strategy, and using technology. The literature on concluding the process of
informed consent emphasizes readability of consent forms, evaluating surrogate
understanding, and ensuring post-consent follow-up. Although the challenges
and strategies surrounding solicitation of surrogate consent apply to all kinds of
research, this paper specifically focuses on genomics research because of the
exceptional nature of genetic information (DNA sequence) and our interest locally
in addressing this important issue (American Thoracic Society, 2004; Cobb,
Mindrinos, Miller-Graziano, Calvano, Baker & Xiao et al. 2005; Feetham et al.
2005; Green & Botkin, 2003; Hook et al. 2004). Also, this paper specifically
focuses on the ICU as a particularly challenging setting because (a) critically ill
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patients are frequently unable to communicate their decisions to a loved one and
(b) a degree of decisional immediacy is required in the ICU that is not usually
necessary in other patient care settings (American Thoracic Society, 2004;
Bigatello et al. 2003).
Approaching the Surrogate
Surrogate Challenges
The nature of critical illness and its treatment frequently prevents direct
verbal interactions between staff and patients. Consequently, surrogates in the
ICU are approached to supply medical histories, therapy decisions and direction,
and a link to the patient’s life before illness (Azoulay & Sprung, 2004; Zaforteza,
Gastaldo, dePedro, Sanchez-Cuenca, & Lastra, 2005). Also surrogates are
called on to make a host of crucial decisions such as choosing among medical
treatments, considering advanced directives, meeting other family members’
needs, attending to financial obligations, and arranging for transportation and
temporary living arrangements (Jamerson et al. 1996). The impact on the
surrogate of the unfamiliar and emotionally charged environment of an ICU is
considerable (Arnold & Kellum, 2003; Azoulay & Sprung, 2004; Jamerson et
al.1996; Pochard, Azoulay, Chevret, Lemaire, Hubert, and Canoui et al. 2001).
For example, Pattison found that the incidence of post-traumatic stress disorder
is high in relatives of patients in the ICU (Pattison, 2005). The initial surprise and
subsequent shock of the loved one’s sudden trauma or illness are compounded
by an unplanned addition of responsibility that requires clear thinking and the
assimilation of rapidly delivered critical and often complex information (Azoulay &
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Sprung, 2004; Jamerson et al.1996; Zaforetza et al. 2005). Within this context,
the surrogate decision maker may be psychologically unprepared to accept the
additional responsibility attendant to enrolling a loved one in a research study
(Azoulay & Sprung, 2004; Davis et al. 2003).
In the context of this highly charged and challenging situation, information
and support may be used as strategies to facilitate surrogates' decision making
Arnold & Kellum, 2003; Azoulay & Sprung, 2004; Jamerson et al.1996). The
opportunity to talk to a health care professional, share cultural values, and voice
concerns can promote understanding and reduce stress (Azoulay & Sprung,
2004; Felgen, 2004; Jamerson et al. 1996; Johnson, Wilson, Cavanaugh,
Bryden, Gudmundson, & Moodley, 1998). Another strategy to empower
surrogates is to give them access to professionals in the ICU including
physicians, primary nurses, nurse specialists, ethicists, spiritual advisors,
independent patient advocates, social workers, and translators (Geller, Botkin,
Green, Pres, Biesecker & Wilfond et al. 1997; Jamerson et al. 1996; Nelson,
Kiyoshi, Meier, Ahmand, & Morrrison, 2005). A study by Arnold and Kellum
(2003) found that an ethics consultation with families of ICU patients was
associated with a shortened ICU stay for their loved ones. When assisted in
exploring and clarifying health care issues, surrogates were empowered to make
health care decisions (Arnold & Kellum, 2003).
Environment
Understanding how the surrogate subjectively perceives the ICU
environment can help health care professionals interpret individual needs and
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behaviors (Felgen, 2004; Jamerson et al. 1996; McLaren & Hawe, 2005).
Recognizing the surrogate’s sense of contrasting environmental dichotomies is
one example. There is a convolution of perceived isolation within a crowded ICU
waiting room that often confronts the surrogate (Jamerson et al. 1996; Johnson
et al. 1998). Even in an atmosphere of hundreds of people in a hospital
community, the surrogate may not be able to identify a support system
(Jamerson et al. 1996). Further, despite the fundamental right to autonomy, the
surrogate may feel compelled to surrender personal and family control to
institutional dictates (American Thoracic Society, 2003; Coppolino & Ackerson,
2001; Geller et al. 1997).
Environmental psychology theory can help guide practice when working with
surrogates in the ICU to improve their decision-making abilities (Bilchick, 2002).
The health care professional can assist the surrogate to interpret or create
alternative perceptions of common ICU stimuli in order to diminish their stressful
impact (Pouchard et al. 2001; Zaforteza et al. 2005). Demystifying the
environment through orientation is an integral component of ethical practice
(Jamerson, 1996). Familiarity with surroundings (sights, sounds, and the
“hospital smell”) can defuse surrogate fear and anxiety. A physical environment
and professional culture that facilitates continuity of care by medical and nursing
staff, information access, flexible visiting hours, and spontaneous interactions are
essential in facilitating surrogate decision making (Jamerson et al. 1996;
Johnson, 1998; Nelson et al. 2005). Providing a private environment when
needed is often useful (Felgen, 2004; Jamerson et al. 1996; Tait, Vopel-Lewis, &
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Malviya, 2003). Some institutions are achieving therapeutic environments
through systems design, practice innovations, and process improvement (Felgen,
2004). As an example, the Pebble Project, a consortium of health care
organizations, uses evidence-based models to create fundamental changes in
hospital design to enhance healing, engage families, and improve public areas,
including the ICU (Bilchick, 2002).
Timing
Deciding when to approach surrogates who may be distressed or distraught,
especially early after an ICU admission, is a significant challenge to the process
of informed consent and ultimately to research participation (Chen et al. 2002;
Shalowitz & Garrett-Mayer, 2006). If surrogates feel rushed to make a decision,
there may be a perception of coercion and a hesitance to trust or relate to the
researcher or the project (Geller et al.1997; Tait et al. 2003). Surrogates need
time to gather information regarding the condition of the loved one before being
asked to consider any proposed research (Jamerson et al. 1996). Consequently,
giving surrogates a place to collect the information they need in order to process
the emotional devastation that accompanies a serious diagnosis, the time to
rebuild and renew relationships, and the opportunity to gather support systems
before approaching them about participation in a research study will facilitate the
process of informed consent and may increase research participation (Hayes,
2003; Jamerson et al.1996). On balance, regular family meetings with the
research team, presentation of the study information in a professional and
relaxed manner, answers to questions, and the opportunity for the surrogate to
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consider the information in a private place for 20-30 minutes before being asked
to give informed consent are fundamental to the ethical conduct of research
(Arnold & Kellum, 2003; Azoulaly & Sprung, 2004).
Legal Aspects
Current regulations about surrogate consent come under the auspices of
Health and Human Services and emanate from the Food and Drug
Administration, NIH, and Offices of Human Research Protection (American
Thoracic Society, 2004; Luce, 2003b). Federal law defines surrogate as one’s
legal representative. Federal law generally defers to the states to define
specifically who a surrogate may be (Bein, 1991; Hook et al. 2004; Fischer,
2006). A few states including California, Arizona, Virginia, and New York
delineate the hierarchy of surrogates from legally appointed representative, to
spouse, children, parent, and sibling. Some states do not recognize surrogate
authority to consent for research (Amdur, Bachir, & Stanton, 2000; American
Thoracic Society, 2004; Benner, 2003; Chen et al. 2002). Because of the lack of
clear guidelines in most states regarding surrogate consent, researchers in ICU
settings rely largely on local Institutional Review Board guidelines and state
human research protections program guidelines for direction (Azoulay & Sprung,
2004; Brody, McCullough, & Sharp, 2005; Luce, 2003b).
Many families and potential surrogates do not discuss advanced directives or
treatment options before an illness or trauma occurs, much less their thoughts on
research participation in the ICU (Bigatello et al. 2003). In fact, Azoulay and
Sprung (2004) found that surrogate judgment was not necessarily in agreement
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with the participant’s own judgment when the loved one’s capacity returned after
critical illness. Coppolino and Ackerson (2001) studied 100 patient-surrogate
dyads to determine how accurately the surrogate would represent the patient’s
wishes in two non-genomic hypothetical research trials in critical care, one
involving minimal risk and the other designated as greater-than-minimal risk. The
results suggest that surrogate’s decisions regarding research participation
differed from those of the patient 16-20% of the time.
In 2004, the American Thoracic Society hosted a multidisciplinary conference
regarding ethical research in the ICU. It concluded that a surrogate with decisionmaking capacity should be identified and that specific laws should be enacted to
establish surrogate rights and responsibilities. Currently, surrogates are directed
to use “substituted judgment” to make research participation decisions (Arnold &
Kellum, 2004; Bigatello et al. 2003; Chen et al. 2002; Shalowitz & Garrett-Mayer,
2006). Substituted judgment is a proxy decision based on what the surrogate
knows about the loved one’s specific wishes in a given situation or the decision
the loved one would make, if competent (Bigatello et al. 2003; Luce, 2003a,
2003b). When the wishes of the loved one are not known, the surrogate must
make a decision about research or treatment based on the loved one’s best
interest (Arnold & Kellum, 2004; Shalowiz & Garrett-Mayer, 2006) While this
approach is not optimal, Arnold and Kellum (2004) reported that over 90% of ICU
patients in the studies they reviewed would rather have had a family member
make their health care decisions along with their doctor rather than the doctor
making these decisions alone. A strategy to assist the surrogate in using
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substituted judgment is for the health care professional to encourage the
surrogate, through targeted dialogue, to recall specific conversations with the
loved one in which the patient’s desires and values were shared (Azoulay,
Chevret, LeLeu, Pochard, Baboteu, & Adrie, 2000; Hayes, 2003)
Misinformation
In addition to not always knowing the patient’s wishes, surrogates often do
not understand the nature of genomics research and may hesitate to enroll loved
ones in research studies because of long-held misconceptions (Bigatello et al.
2003, Chenaud, Merlani, Luyasu, & Ricou, 2006). Sex, class, race, and cultural
characteristics also affect how genomics information is perceived and may
perpetuate misconceptions that could have a profound influence on surrogate
participation (Benner, 2003; Geller et al.1997; Ho, 2006; Jenkins, 2001). One
common misconception is the notion of determinism (Chenaud et al. 2006;
Feetham et al. 2005). Determinism, in this instance, refers to the idea that an
individual’s genetic makeup will cause one to behave in a certain way or the body
to perform in a certain manner, leading to the misconception that genetic
predispositions are absolute. For example, the sequence of the human genome,
touted as the “Book of Life”, may cause consumers of health care to believe that
their characteristics and their health are predestined, when, in fact, it has been
estimated that only 50% of phenotype is determined by genetics (Anderson &
Nickerson, 2005; Brody et al. 2005; Guttmacher & Collins, 2003; Miller & Brody,
2003; Ojha & Thertulien, 2005; A second major mistaken notion is the
therapeutic misconception (American Thoracic Society, 2004; Brody et al., 2005;
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Chen et al. 2002; Joffe, Cook, Cleary, Clark & Weeks, 2001a; Joffe, et al. 2001b;
Silverman et al. 2005; Stead, Eadie, Gordon, & Angus, 2005). This occurs when,
despite receiving detailed information to the contrary, many surrogates enroll
their loved ones in studies believing that the participants will receive an
immediate and direct therapeutic benefit (Joffe et al. 2001a). In the case of
randomized controlled trials, for example, surrogates often do not believe that the
research will not benefit the patient directly, that the researcher does not know
which treatment the participant is receiving, or that the researcher really does not
know which protocol is the better one (Flory & Emmanuel, 2004).
Because of the misconceptions surrogates may have, it is important to
approach them in a way that encourages open discussion of preconceived ideas
about genomics research in the ICU. Geller et al. suggest that surrogates
examine their fears and motives when agreeing to genomics research (Geller et
al. 1997). They also advise health care professionals to tactfully elicit personal
and cultural perceptions surrounding genomics, correct misconceptions, and
develop educational strategies to increase understanding of genomics research.
These strategies may help the surrogate to adopt a more realistic view of
research benefits and limitations. Lastly, it is important that the health care
professional emphasize that clinical research is rarely designed to benefit the
participant directly (Miller & Brody, 2003; Silverman et al. 2005; Stead et al.
2005). With careful attention to the surrogate’s need to understand how the loved
one fits into the research process, it is more likely that surrogates will visualize
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themselves and their loved ones as an integral part of the research process
(Stead et al. 2005).
Educating the Surrogate
Language and Literacy Challenges
Surrogate education to facilitate informed decision making becomes even
more challenging when language or literacy challenges are added to an already
complex decision making process (Geller et al. 1997). For example, the
interpreting skills of family translators may be inadequate resulting in the
communication of misinformation, especially regarding health information. Family
translators also are not desirable because they may violate patient privacy and
may present conflicts of interest. Clearly, professional interpreters should be
used when critical or complex information must be conveyed (Azoulay et al.
2000). Other strategies to address language and literacy issues include
becoming familiar with societal and governmental mandates related to literacy,
patient education, linguistic resources, and multicultural resources (Azoulay &
Sprung, 2004; Joffe et al. 2001a; Joffe et al. 2001b). Offering an audio recording
of educational sessions would allow the surrogate to review information
independently (Arnold & Kellum, 2003). The use of specially equipped computer
communication devices such as translating programs, pictorial supplements to
text, and speech recognition also may be useful (Dreger & Tremback, 2002;
Jimison, Sher, Appleyard, & LeVernois, 1998). Actively assessing surrogates for
language and literacy barriers will help the health care professional choose
appropriate techniques to facilitate surrogate education.
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Teaching the Elements of Consent
Greater attention is needed toward educating surrogates about essential
elements of the process of informed consent (Table 1). Items 1,3,4,5,6, elements
in Table 1 are derived directly from the Code of Federal Regulations (Flory &
Emanuel, 2004; Schats, Brilstra, Rinkel, Algra, & VanGijn, 2003; U.S.
Department of Health and Human Services; 1991). The next essential element is
the ELSI considerations (U.S. Department of Energy, 2005). Another essential
element is ownership and security of stored specimens (Azoulay et al. 2000;
Jeffers, 2001; Prows, Glass, Nicol, Skirton, & Williams, 2005; Topol, Murray, &
Frazer, 2007). Regarding ownership, even when consent is withdrawn,
surrogates should know that recent legal decisions may prevent previously
collected specimens from being destroyed (Harris, 2006). The last essential
element of the process concerns the role of the surrogate and substituted
judgment (Coppolino et al. 1997). The surrogate must be taught and be able to
demonstrate an understanding of all of the elements of consent before the
consent form is signed.
Choosing a Teaching Strategy
Given the challenges associated with surrogate learning, using multiple
educational strategies based on surrogates’ preferred learning styles may be
useful (Dreger & Tremback, 2002; Geller et al.1997) Decisional aids and written
information that support the educational needs of surrogates may increase their
satisfaction in the decision-making process and reduce conflicts between
surrogates and staff (Arnold & Kellum, 2003; Azoulay & Sprung, 2004; Geller et
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al.1997). Surrogates benefit from repetition of information delivered in small
increments over time and from repeating concepts back to the educator (Dreger
& Tremback, 2002; Geller et al.1997). Ryan and Lauver (2002) analyzed 20
research studies that used tailored informational interventions in home care to
improve health outcomes in elders. All outcomes related to the tailored
interventions were equal to or better than the standard informational intervention.
Another study, conducted in a community hospital among elderly patients, used a
multimedia strategy and found increased knowledge about non-drug pain control
strategies among those given a tailored educational program (Tracy, Dufault,
Kogut, Martin, Rossi, & Willey-Temkin, 2006). Additional strategies to enhance
the use of multimedia educational tools include the use of printed materials with
Braille, large type, serif fonts, and contrasting color (Davis et al, 2003).
Using Technology
Interactive computer-based and Internet-based educational tools are
attractive options for educating surrogate decision makers in the ICU (Arnold &
Kellum, 2003; Geller et al.1997). However, most research on the use of these
approaches has been conducted in patients with chronic illness (Bond, 2006).
Ideally, interactive computer-based and web-based educational tools would
assist the surrogate to increase knowledge, facilitate skill development, enact
behavioral change, and enhance decision making (Arnold & Kellum, 2003; Bond,
2006; Jimison et al.1998). There are many advantages to using interactive
computer programs as teaching tools: (a) they can be accessed any time of the
day or night and Web-based programs can be accessed anywhere an Internet
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connection is available; (b) learning can be reinforced immediately; (c) the
material presented does not vary; (d) basic information can be provided with links
and explanations to more sophisticated and detailed information; and (e)
multimedia presentations that provide clear examples can be used (Bond, 2006;
Lewis, 2003).
Although the effectiveness of interactive and Web-based education has not
been definitively established, there have been some encouraging results. For
example, a web-based information program for families of nursing home
residents used the Technological Readiness Index to explore their likelihood of
using the technology for education (Rosen, Mittal, Mulsant, Degenholtz, Castle, &
Fox, 2003). According to the Technology Acceptance Model, people use
technology if it is user-friendly and provides satisfaction. Participants, the majority
being elderly with limited computer experience, were able to complete the
program and were very satisfied with the intervention (Rosen et al. 2003).
Similarly, the Personal Education Program (PEP) using computer-based
information was designed to supplement face-to-face interactions between
nurses and older clients. An evaluation of PEP indicated that elderly clients were
successful in utilizing computerized technology for acquiring information
(Neafsey, 2003). Also a randomized controlled trial indicated that a computerized
Interactive Multimedia Program for Asthma Control and Tracking was a good
adjunct to traditional asthma educational interventions in children and caregivers
(Krishna, Francisco, Balas, & Konig, Graff, & Madson, 2003). Another out-patient
study, investigating the effect of providing computerized, anonymous, non-
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judgmental, information to breast cancer patients, found that it fostered selfefficacy to a greater degree than a pamphlet only (Reis, Trackel, King, &
Remmert, 2004). It is not surprising, then, that the Society of Critical Care
Medicine as well as the American Thoracic Society support the development of
interactive Web-based education that can empower individual learners to satisfy
personal educational needs (Flory & Emanuel, 2004; Bond, 2006).
Challenges to the use of these strategies with surrogates in the ICU setting
include the substantial cost for computer hardware, software, support, and web
accessibility. Further, factors which interfere with surrogates’ readiness to learn
include anxiety, fear, and discomfort (Azoulay & Sprung; 2004; Pochard et al.
2001). Also economic, cultural, and demographic factors may stratify surrogates
in their ability to use technology (Lewis,1999; Lewis, 2003).
Face-to-face follow-up has been shown to increase the effectiveness of
interactive computerized educational programs for surrogates (Davis et al. 2003;
Geller et al.1997; Silverman et al. 2005). Although there is little information
available in the literature regarding surrogate computerized education in the ICU,
the surrogates described in these studies are likely to be similar in age and
education to surrogates in the ICU setting. Because of the potential usefulness of
computer-based programs for surrogate education in the ICU, it follows then that
developing computer-based learning tools for surrogate education in the ICU
would be a worthy deliverable.
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Concluding the Process of Informed Consent
Readability of Consent Forms
Concluding the consent process with difficult to read informed consent forms
may provoke frustration, confusion, and doubt (Geller et al.1997; Stead et al.
2005). In fact, the readability of consent documents is too complicated for up to
60% of patients and surrogates (Burkell & Campbell, 2005). Level of education
often does not correlate with reading ability and cannot be used to determine the
appropriateness of written material. Davis et al. (2003) recommended developing
written materials at a sixth grade reading level. Yet, Stead et al. (2005) cautioned
that important information may be lost as the document is simplified. One study
which examined a variety of consent forms concluded that the forms should be
shortened and simplified, use lay language, and include a glossary or video to
emphasize important information (Flory & Emanuel, 2004; Silverman et al. 2005).
Multimedia consent forms, such as computer-based educational programs, may
be helpful in many patient populations (Lewis, 2003).
Evaluating Surrogate Understanding
Surrogates’ understanding of essential information must be evaluated prior to
concluding the consent process. Tait et al. (2003) conducted a study involving
the parents of 505 pediatric patients in a preoperative environment. Parents were
interviewed to determine their level of knowledge and understanding of
information presented. Although parents reported that they had a good
understanding of the research project that had been described to them, only 59%
of the parents understood the purpose of the study and only 33% understood the
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confidentiality policy. Similarly, Schats et al. (2003) asked patients and their
relatives to recall critical information presented in the process of informed
consent several months after signing the form. The authors found that only 14%
of participants could spontaneously recall one or more details of the essential
elements of consent, whereas none could recall all of the elements. Wendler
(2004) has reported that 40% of potential research participants, after signing the
consent form, do not understand the essential elements of informed consent and
may still fail to understand them even after an educational intervention. Nelson et
al. (2005) stated that half of the families of patients in ICU do not have a basic
understanding of the information they are given, such as information on
treatments, prognosis, or research.
Geller et al. addressed this concern with the use of a two-part consent form.
Part one explained the study while part two asked specific questions concerning
the content of part one (Geller et al. 1997). Using such an approach,
misconceptions can be corrected, remedial teaching can be done, and questions
can be answered. Another strategy, the Deaconess Informed Consent
Comprehension Test, uses a verbal test designed to quantify a participant’s
knowledge of the elements of informed consent. A strength of this instrument is
the immediate correction of misconceptions (Silverman et al. 2005; Wendler,
2004). Additionally, the Quality of Informed Consent for Cancer Trials instrument
was developed to evaluate patients’ understanding of essential concepts in the
process of informed consent and to establish whether the “therapeutic
misconception” persists (Joffe et al. 2001a; Joffe et al 2001b; Silverman, 2005).
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Ultimately, whatever methods are used, a signature on an informed consent form
should be solicited only after it has been determined that the surrogate
understands the materials presented (American Thoracic Society 2004).
Post Consent Follow-Up
The consent process does not end after the consent form is signed because
the researcher must also provide post consent follow-up, which includes
periodically apprising the surrogate of the patient’s situation (Azoulay & Sprung,
2004; Hook et al. 2004; Pochard et al. 2001; Luce, 2003a). Continuity of care
over time, especially with the patient’s primary physician, facilitates the provision
of consistent and clear information (Azoulay & Sprung, 2004). The surrogate
must have current contact information for the researcher throughout the entire
process, including follow-up (Geller et al. 1997). Finally, should the patient regain
decision-making capacity, obtaining consent directly from the patient should be
considered (Chen et al. 2002; Bigatello, et al. 2003).
Conclusion
Health care professionals have both an ethical responsibility to protect and
advocate for their patients during the process of informed consent and the legal
accountability that occurs with witnessing a consent document (Azoulay et al.
2000; Urbanski, 1997; Wendler, 2004). The ICU is a particularly challenging
environment, in which obtaining surrogate consent may be difficult due to
personal, environmental, logistical, educational, and ethical considerations
(Beery & Hern, 2004; Fuller, Kahn, Ellis, Barr, Biesecker, & Crowley, 1999; Kim,
Appelbaum, Jeste, & Olin, 2004). Jeffers argues that identifying and dealing with
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ethical issues, as genetic and genomics research continues to develop, may
prevent future conflicts in values, respect, and human dignity (Jeffers, 2001).
The three steps of the process of informed consent (approaching the
surrogate, educating the surrogate, and concluding the process of informed
consent) can be used as a framework with which to construct, implement, and
evaluate human studies policies to effectively and ethically obtain surrogate
consent for genomics research in the ICU. Beery and Hern (2004) and Azoulay
and Sprung (2004) encourage institutions to mobilize resources to improve the
skill sets of health care professionals in evaluating families for potential barriers
to surrogate decision making. With knowledge in pharmacogenomics, genetic
testing, referrals, education, counseling, treatments, and research, health care
professionals can take the lead in educating stakeholders regarding priorities and
policies about privacy, the use of information and biological specimens, ethical
conduct of research, at-risk individuals and groups, case management priorities,
and educational and computer resources as they relate to the ICU setting
(Chung, Laramie, Province, & Cobb, 2002; Conley & Tinkle, 2007, Feetham et
al. 2005; Hook et al. 2004, Jenkins & Calzone, 2007; Ojha & Thertulien, 2005;
Prows et al. 2005).
Currently available data on obtaining informed consent are insufficient to
adequately guide patients, surrogates, and health care professionals in the ICU
setting reflecting great challenges for the future (Jenkins, Grady, & Collins,
2005). New research on education and informed consent that leverages the
power of computers and the internet is especially needed.
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Stewardship Models of Genetics and Genomics Research
Two models of stewardship of genetic and genomics research are presented.
The models help explain the stewardship responsibilities implicit in informed
consent for genetic and genomics research and particularly for the difficult
challenges experienced by surrogates in the ICU.
The Jeffers’ Emerging Model of Research Risk focuses on stored information
and human biological specimens. It illustrates the need for human rights
protections by minimizing research risk. Second, the author-developed model of
stewardship of genetic and genomics research expands the ideas in the Jeffers’
model to illustrate the concept of stewardship of genetic and genomics research
and the balance necessary to conduct needed research with the protection of
human rights.
Jeffers’ Emerging Model of Research Risk
Jeffers (2001) utilized the recommendations of the National Bioethics
Advisory Commission (2001) and developed a model of stewardship as it relates
to genetic and genomics research specifically concerned with human tissue and
biological samples (Figure I). Genetic information, according to Jeffers, has both
social value and social risk (Jeffers, 2001). The risks include privacy,
confidentiality, stigmatization of families and communities, prospective consent
issues, and commercialization of donated human biological material (Jeffers,
2001).
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Stewardship Model of Genetic and Genomics Research
The stewardship model of genetic and genomics research is presented as a
balance scale as depicted in Figure 2. The scale is composed of a fulcrum, a
lever, and a pivot point on which stewardship is balanced. The fulcrum
represents responsibility and its critical attributes: trust and accountability. The
lever, situated on the pivot point of the fulcrum, represents the continuum of
stewardship. At one end of the lever is the mandate for genetic and genomics
research and at the other end of the lever is the preservation and protection of
human rights which is comprised of community rights, family rights, and
individual rights. The inclusion of family and community in the protections of
human rights exemplifies the uniqueness of genetic and genomics research in
contrast to the emphasis of autonomy and individual rights essential in other
forms of research. If too much emphasis is placed on the research mandate of
genetic and genomics research then human rights may be violated. If too much
emphasis is placed on human rights, then little genetic and genomics research
will be conducted. A balance between these factors is ideal and represents the
balance necessary for stewardship to occur.
Summary
This chapter summarized theoretical and research aspects about informed
consent and the stewardship of genetic and genomics research in the ICU.
Further research is needed to better understand the implications of genetic and
genomics research in the ICU, to promote stewardship of genetic and genomics
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research, and to inform and educate stakeholders about genetic and genomics
research.
CHAPTER III
Introduction
Chapter III includes hypotheses and methods. Within methods, design,
sample and setting, instruments, intervention, data collection procedures, and
data analysis are presented.
Hypotheses
Hypothesis I
Understanding of the process of informed consent will be greater in the
experimental group as compared to the control group.
Hypothesis II
Knowledge of genetic and genomics research will be greater in the
experimental group as compared to the control group.
Methods
The protocol and the flyers were approved by Washington University and the
University of Missouri – St. Louis IRB. Data collection began in March, 2008 and
was completed in August, 2008.
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Design
This study has a cross-sectional, prospective, experimental posttest design
with a control group and random assignment to group. The experimental group
received the ICIS ICU Education Program plus the Sample Consent Form and
the control group received the Sample Consent Form alone.

Experimental

X

O

RA
Control

O

Sample and Setting
Subsequently, Internal Review Board approval was obtained from the
hospital and from the University of Missouri – St. Louis prior to initiating the study
(Appendix B, Figures 5, 6).
Two intensive care waiting rooms in a major metropolitan area health center
were used as the setting for the current study. There were 134 participants in the
current study. The inclusion criteria for this study included (a) visitors to specific
medical center’s ICU waiting rooms, (b) age 18 or older, and (c) willingness to
participate in the study. The exclusion criteria for the current study included (a)
under 18 years of age, and (b) unwilling or unable to participate in the study.
Using Cohen’s table, a power analysis was conducted, indicating a need for
a total of 64 participants per group to detect a .50 effect with a power of .80, and
an alpha value of .05.
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Instruments
The Posttest Instrument is an author-developed 14-question multiple-choice
questionnaire. It was designed to determine the extent to which the ICIS ICU
Education Program would increase understanding of the process of informed
consent and knowledge of genetic and genomics research among experimental
group participants in the ICU. Thirteen questions are directed to the
understanding of informed consent and one question concerns knowledge of
genetic and genomics research. No reliability of this instrument has been
established. Cronbach’s alpha will be calculated during data analysis. Face and
content validity was established through the use of a content analysis table and
examination by the dissertation committee (Table 2). Construct validity was
specifically derived from guidelines from the Code of Federal Regulation
concerning informed consent (U. S. Department of Health and Human Services,
1991). Both the experimental group and the control group completed the 14question Posttest Instrument.
Intervention
The Interactive Computerized Information for Surrogates (ICIS) ICU
Education Program is an author-developed educational program which uses a
series of 36 slides to inform and instruct a potential surrogate visiting the ICU
about the process of informed consent and the ethical conduct of genetic and
genomics research and its ELSI components. The ICIS ICU Education Program
Content Analysis Table for the Essential Elements of Informed Consent can be
found in Appendix A, Table 2. The content analysis table shows the concepts of
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informed consent and genetics and genomics and connects them with the slides
in the ICIS ICU Education Program and the 14 questions on the Posttest
Instrument. The intervention is available from the author on request. The
experimental group received the ICIS ICU Education Program plus the Sample
Consent Form and the control group received the Sample Consent Form alone.
Data Collection Procedures
Using a random numbers table, participants will be randomly assigned to the
experimental group or the control group. The experimental group was given up to
ten minutes to complete the ICIS ICU Education Program. Then, the participant
was given the Sample Consent Form to read. The Sample Consent Form
required up to ten minutes to read. The interview script was read to the
participant and responses recorded. The participant was asked to complete the
Posttest Instrument requiring about five minutes and a demographic form
requiring about five minutes.
The control group was given the Sample Consent Form only and was given
ten minutes to read the material. The interview script was read to the participant
and responses recorded. Then control group participants were asked to complete
a Posttest Instrument requiring about five minutes and a demographic form
requiring about five minutes.
The duration of the study was between 20 and 30 minutes in total. A
corrected Posttest Instrument key was given to each participant after the study to
minimize reinforcement of misperceptions. There was no remuneration.
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Data Analysis
Using SAS, descriptive statistics were used to define sample characteristics.
A Student t-test was used to compare the means of the Posttest Instrument
scores between the experimental group and the control group. The assumption
of normality required for the Student t-test was violated as indicated by the
Shapiro-Wilk test conducted on each item for both groups. Data transformation
attempts were unsuccessful. Since the normality of the data could not be
assumed, Fisher’s exact test was used. Missing data were imputed using the
grand means where required. Missing data was left blank when describing
individual items. Multiple regression was used to test the relationships specifically
between the groups and the posttest scores. The nonparametric Wilcoxon Test
of Two Independent Samples was used for interval and ratio data and the Levine
test for equality of variance also was used. Top Box statistics were computed to
further illustrate the differences between the experimental group and the control
group. Top Box considers the actual number of participants that chose the most
correct answer (5) for each posttest question for both the experimental group and
the control group to make a determination of effectiveness of the ICIS ICU
Education Program.
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CHAPTER IV
Introduction
In Chapter IV, the hypotheses, results, and a summary of the results are
presented.
Hypotheses
Hypothesis I: Understanding of the process of informed consent will be
greater in the experimental group as compared to the control group.
Hypothesis II: Knowledge of genetic and genomics research will be greater in
the experimental group as compared to the control group.
Results
Sample Characteristics
A total of 137 visitors (potential surrogates) in the surgical/trauma and
cardiac ICU waiting rooms participated in this study from May 2008 to August
2008. Three participants were called away during the session and did not
complete the study. Therefore, there were a total of 134 participants. There were
65 (48.5%) participants in the experimental group and 69 (51.5%) participants in
the control group. Table 3 presents sample characteristics of study participants.
Participant ages ranged from 19-82 (M = 47.3; SD = 15.19) (see Table 3).
There were 45 men (33.6%) and 89 women (66.4%) in the sample. There were
33 African Americans participants (24.6%), 100 Caucasian participants (74.6%),
and 1 Hispanic participant (0.75%). Level of education in the sample ranged
from less than a high school degree to those with a post-graduate degree. Most
typically, the relationship to the patient was parent, child, or other. Participants
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had widely ranging occupations. Four participants were health care workers. One
health care worker was a chaplain, and three were RN’s. One participant was a
non-professional recruiter for a medical research firm. Using Fisher’s Exact test,
groups did not differ significantly by age (decade or other age categories),
gender, race, education level, or relationship to the patient (see Table 3). In
summary, the sample was predominantly female and Caucasian, at an education
level mostly of high school, some college, or college, and whose relationship to
the patient was most typically parent, child, or other.
Missing Data
There were four different missing data points on three posttest measures
from participant 24, 45, and 57. Table 4 presents characteristics of participants
with missing data points. Item 13 explains that a surrogate has the right to know
if there is a plan for compensation for harm that might come to a subject during
research. Item 2 defines genomics. Item 4 concerns whether the surrogate may
or may not withdraw from research until it is finished. Item 3 states that a lovedone may be too ill to agree to participate in research. When that happens, the
surrogate may be asked to give permission for research participation.
Regression
Using linear regression, no relationship was found between age, gender,
race, education, relationship to the patient, and previous participation in medical
research and the outcomes: understanding of the process of informed consent
and the knowledge of genetic and genomics research.
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Hypothesis Testing
Hypothesis I: Understanding the Process of Informed Consent Will be Greater in
the Experimental Group as Compared to the Control Group
Hypothesis I was accepted. Items 1 and 3-14 were designed to measure the
understanding of the process of informed consent among surrogates in the ICU.
Overall, understanding the process of informed consent was significantly higher
in the experimental versus the control group (Wilcoxon W = 3346; p = 0.000).
Differences in mean scores between groups pertaining to understanding the
process of informed consent were greatest in Items 3, 11, and 14. Specifically, 8
of the 13 items tested were significantly (p < 0.05) higher in the experimental
versus the control group, namely: Items 1, 3, 4, 7, 8, 11, 13, 14 (see Table 5).
The Top Box showed the percentage of participants by group that picked the
most correct response (5) for each of the 13 questions and its chi-square p-value
(see Table 6). Participants in the experimental group chose the most correct
response (5) significantly more often than the control group for Items 1, 3, 4, 7, 8,
11, 13, and 14. Findings about the understanding of the process of informed
consent were the same between the analysis of items and the Top Box approach
for Hypothesis I.
Hypothesis II: Knowledge of Genetic and Genomics Research Will be Greater in
the Experimental Group Compared to the Control Group
Hypothesis II was accepted. Item 2 was designed to measure the knowledge
of genetic and genomics research among surrogates in the ICU. Table 5 showed
that knowledge of genetics and genomics research was significantly higher in the
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experimental versus the control group for Item 2 (Wilcoxon W 3853.5, p = 0.000).
In addition, Top Box showed the percentage of participants by group that picked
the most correct response (5) for Item 2 and its chi-square p-value (Table 6).
Findings about the knowledge of genetic and genomics research were found to
be the same between the analysis of the items and the Top Box approach for
Hypothesis II.
Further Analyses
Items Covered in the ICIS ICU Education Program and Items Covered in the
Sample Consent Form
The ICIS ICU Education Program was designed to educate the surrogate
about 14 essential elements of informed consent regarding genetic and
genomics research, hence the 14 Items. Table 2 depicts the 14 essential
elements as covered in the ICIS ICU Education Program and the Sample
Consent Form. All the elements are covered using slides in the ICIS ICU
Education Program. The Sample Consent Form gives information only on Items
1, 4, 5, 6, 8, 10, 12, 13, and 14.
Cases Where the ICIS ICU Education Program Plus the Sample Consent Form
was Effective Above and Beyond the Sample Consent Form Alone and the
Sample Consent Form Provided Information (Items 1, 4, 8, 13, 14)
Table 5 shows the five cases where the ICIS ICU Education Program plus
the Sample Consent Form augmented the information in the Sample Consent
Form alone (Items 1, 4, 8, 13, 14). Regarding Item 13, eleven participants
erroneously thought that the portion of the Sample Informed Consent Form
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instructing the reader about who to contact if they felt they had been harmed
during research, believed they had read that there was no compensation for
harm available.
Cases Where the ICIS ICU Education Program Plus the Sample Consent Form
was not Effective Above and Beyond the Sample Consent Form Alone and The
Sample Consent Form Provided Information (Items 5, 6, 10, 12)
Table 5 shows 4 cases where the ICIS ICU Education Program plus the
Sample Consent Form did not augment the information in the Sample Consent
Form (Items 5, 6, 10, 12). In these cases, the information on the Sample Consent
Form was very adequate, diminishing any differences between groups.
Cases Where the ICIS ICU Education Program Plus the Sample Consent Form
was Superior to the Sample Consent Form Alone and the Sample Consent Form
Provided No Information (Items 2, 3, 7, 11)
Table 5 shows that the ICIS ICU Education Program plus the Sample
Consent Form provided the missing information in Items 2, 3, 7, and 11 when the
Sample Consent Form provided no information.
Cases Where the ICIS ICU Education Program Plus the Sample Consent Form
was not Superior to the Sample Consent Form Alone and the Sample Consent
Form Provided No Information (Item 9)
In one case (Item 9) the ICIS ICU Education Program plus the Sample
Consent Form did not provide significant information where there was no
information given in the Sample Consent Form. It is likely, therefore, that the ICIS
ICU Education Program could not provide significant information regarding this
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item because the idea that the researcher must give you all the information you
need to make an informed decision about research is common knowledge
among the public. Overall, these findings provide support for the decision that the
ICIS ICU Education Program does not need to be modified, even though at first
glance it looked like the ICIS ICU Education Program was not effective for some
items.
Instrument Reliability
Internal consistency reliability of the Posttest Instrument was evaluated using
Cronbach’s alpha (0.730), indicating moderately-high reliability. Internal
consistency reliability for the questions related to Hypothesis I (1 and 3-14) was
0.723. Cronbach’s alpha could not be computed for Item 2 alone.
Additional Findings
Results From the Posttest Instrument as a Whole
Using the Wilcoxon test, the total score on the Posttest Instrument was
significantly (p <.05) higher in the experimental versus the control group.
Past Participation in Medical Research
There were 11 participants who had participated in medical research prior to
this study. The majority of those participants (n = 9) felt that they received
sufficient information to make an informed decision as to whether or not to
participate in the research and two felt that they did not.
Responses to the Scripted Question
Table 7 lists a sample of responses to the scripted question asked of each
participant: “Thank you for reading the sample informed consent form. What
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questions would you need to ask to understand this research?” There were no
questions directly related to the Sample Consent Form. There were several
comments and questions about why the study was designed the way it was and
the concept of substituted judgment.
Reasons for Not Participating in the Study
Table 9 is a summary of comments made by participants who declined to
participate in the current study, (e.g. “I am just too tired; I’ve been here since four
in the morning.” Another reason frequently given was: “I can’t think right now.” A
third reason was: “I have too much on my mind.”) Visitors who declined
participation cited their intention to see their loved-one soon, to go to get
something to eat, or to go home.
Summary
The current study was conducted with predominately female participants.
The groups did not significantly differ by age, race, education, or relationship to
the patient. No significant relationships were found between sample
characteristics and either the understanding of the process of informed consent
or the knowledge of genetic and genomics research. Overall, participants in the
experimental group had significantly greater understanding of the process of
informed consent and a significantly greater knowledge of genetic and genomics
research. These findings were substantiated by the fact that most items were
significantly higher in the experimental versus the control group and by the fact
that the most correct top box (5) answer choice was chosen significantly more
often by the experimental versus the control group. The Posttest Instrument was
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shown to be a reliable measure overall, and regarding the understanding of the
process of informed consent. Reliability of the Posttest Instrument in measuring
the knowledge of genetic and genomics research could not be determined.
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CHAPTER V
Introduction
In Chapter V, the summary of the problem, the problem statement and the
purpose, as well as the findings are discussed. This chapter also presented study
limitations and implications for nursing theory, nursing practice, nursing science
and future research. Finally, conclusions are presented.
Summary of the Problem
The U.S. Centers for Disease Control and Prevention state that there is
some genetic component influencing most disease processes (Beery & Hern,
2004). Understanding the etiology of illness, predicting therapeutic effects or
adverse medication reactions, and developing testing and treatment innovations
constitutes the promise of genomics research and will transform the provision of
health care (Beery & Hern, 2004; Collins et al. 2003). This understanding of
genetics and genomics is critical to the clinical application of new knowledge of
health and disease gleaned from research such as the Human Genome Project.
Since the inception of the Human Genome Project, there has been an ongoing
ELSI of genetic research. Fundamental ELSI considerations such as privacy,
confidentiality, insurability, and discrimination impact stakeholders involved in
genetic and genomics research. In fact, project developers anticipated the
enormity of ELSI to the Human Genome Project and designated approximately
3% – 5% of the total NIH Human Genome Project funding package to study its
impact on individuals, families, communities, and institutions (Ojha & Thertulien,
2005).
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Critically ill ICU patients often are unable to consent to participate in genetic
and genomics research due to cognitive impairment associated with trauma,
fever, sedation, pain, or shock (Davis, et al., 2003; Freeman, et al. 2006;
Jamerson et al. 1996). Therefore, surrogate, or proxy, consent may be desired
in an emergent situation for which study enrollment cannot be delayed. Surrogate
informed consent is a critical component of genomics research in the ICU. Yet,
surrogates are asked to make complex research participation decisions for their
loved-ones in the ICU; many of whom have an insufficient understanding of the
process of informed consent and insufficient knowledge of genetics and
genomics research (Davis et al. 2003; Jamerson et al. 1996).
Summary of the Problem Statement
There is a paucity of research about the surrogate consenter’s understanding
of the process of informed consent and knowledge of genetic and genomics
research in the ICU. Yet, surrogate decision makers are called upon to give their
consent for loved-ones to participate in genomics research with its ELSI
considerations. Little is known about the surrogate decision maker experience as
it relates to understanding the information disclosed in the process of informed
consent or knowledge of genomics research. Thus, surrogates approached to
authorize participation for a loved-one in genomics research in the ICU may be
ill-prepared to make these decisions. In fact, there are no published papers
focusing specifically on an intervention to facilitate surrogate informed consent
for genetic or genomics research in the ICU. An education intervention may have
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the potential to enhance the understanding of the process of informed consent
and knowledge of genetic and genomics research in surrogates in the ICU.
Summary of the Purpose
The purpose of this investigation is to examine the effectiveness of an
educational program, the Interactive Computerized Information for Surrogates
ICU Education Program (ICIS) in assisting surrogates to (1) increase
understanding of the process of informed consent and (2) increase knowledge of
genetic and genomics research.
Discussion of Results
Of the 134 participants in the study, 66% were women and 34% were men.
There were more women visitors to the ICU waiting room than men. The average
study participant was middle aged with a mean age of 47 years. There were 33
African American participants, 100 Caucasian participants, and one Hispanic. In
summary, the sample was predominantly female and Caucasian, at an education
level mostly of high school, some college, or college, and whose relationship to
the patient was most typically parent, child, or other. The experimental and the
control groups did not differ by age, race, education, or relationship to the patient.
Hypothesis I and Hypothesis II were accepted. Understanding the process
of informed consent was significantly higher in the experimental group than the
control group. Additionally, knowledge of genetic and genomics research was
significantly higher in the experimental group compared to the control group.
The ICIS ICU Education Program provided adequate information. No
modifications of the ICIS ICU Education Program are recommended. The
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Sample Consent Form lacks information on Items 2, 3, 7, 9, and 11 which are
related to surrogate informed consent, the knowledge of genetic and genomics
research, and the purpose of the Institutional Review Board. Likewise, surrogates
must know that they have a right to all of the information they need to make a
research decision and that they have a responsibility to represent the patient in
making research decisions. However no recommendation is made regarding
modifications of the Sample Consent Form because it is an IRB-approved form,
meeting the requirements of IRB, and it already contains five pages of
information. Moreover, Items 2, 3, 7, 9, and 11 go beyond the scope of the
purpose of the Sample Consent Form. Review of the clarity of information on
harm in the Sample Consent Form is suggested.
Because the essential elements reflected in Items 2, 3, 7, 9, and 11 are
critical to the conduct of genetic and genomics research in the ICU with surrogate
consent, and because the Sample Consent Form is inadequate regarding this
information, it is recommended that the ICIS ICU Education Program be
administered prior to the Sample Consent Form to augment information given in
the Sample Consent Form when genetic and genomics research in the ICU with
surrogate consent is conducted.
Study Limitations
Only one Hispanic participant was recruited and the rest were AfricanAmerican and Caucasian. There were no Asian, Bosnian, Native American,
Pacific Islanders or Vietnamese known to have visited the ICU waiting room
during data collection. This lack of diversity is a limitation of the current study.
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Also, study findings might have been different if a different Sample Consent Form
was used. Additionally, the current study used an author-developed education
program and an author-developed Posttest Instrument that were tested for the
first time in the current study. The instrument will require additional reliability and
validity testing. In addition, the study was conducted in two ICU waiting rooms
from one institution and may not be generalizable to other ICU waiting rooms.
Finally, transitory personal factors, such as fatigue, hunger, mood, fear, and
anxiety could have possibly caused errors of measurement.
Implications for Nursing Theory
Stewardship was not the focus of the current study, but the author-developed
stewardship model was used as the overarching framework in the study,
specifically in the development of the ICIS ICU Education Program. The
stewardship model and the ICIS ICU Education Program adds to nursing’s body
of knowledge in the development of nursing theory in this area. In addition, each
of Carper’s four patterns of knowing in nursing, empirical knowledge, aesthetic
knowledge, personal knowledge, and ethical knowledge, was used in the
development of the stewardship model, ICIS Education Program, and Posttest
Instrument (Carper, 1978). Along with aesthetic knowing, environmental theory
also was used to comprehend the challenges of the ICU environment to the
surrogate (Bilchick, 2002; Felgen, 2004; Malkin, 2002; McLaren & Hawe, 2005).
Ethical knowing was used to create the ICIS ICU Education Program slides that
were based on the Federal Common Rule (U. S. Department of Health and
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Human Services, 1991). Finally, the Posttest Instrument tested the participant
about their understanding of informed consent which contains ethical concepts.
Implications for Nursing Practice
Recognizing the significance of genetics and genomics to the future of health
care and the future of nursing practice, the American Nurses Association
published “Essential Nursing Competencies and Curricula Guidelines for
Genetics and Genomics” in conjunction with the National Human Genome
Research Institute (NHGRI), National Institutes of Health (NIH), and the Office of
Rare Diseases (Consensus Panel, 2006). Genetics and genomics will influence
nursing practice as the prevention, diagnosis, and treatment of illness and injury
and the realization of personalized health care emerge as deliverables of genetic
and genomics research. Teaching is a major role in nursing practice and the
availability of educational materials such as the ICIS ICU Education Program will
give nurses new strategies with which to inform stakeholders about the future of
genetic and genomics research in health care.
Implications for Nursing Science and Future Research
Genetic and genomic discoveries have increased ELSI concerns and policy
debates (NHGRI, 2001). Nurses, are consistently identified as respected and
trusted professionals. As such, nurses are ideally suited to address ELSI
concerns and facilitate the stewardship of genetic and genomics research by
balancing the mandate of genetic and genomics research with the protection of
human rights. The ICIS ICU Education Program can be used to increase
surrogate’s understanding of the process of informed consent and increase their
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knowledge of genetic and genomics research thereby ensuring the balance
between needed research and human rights protections. In fact, when
practitioners are properly in-serviced, the ICIS ICU Education Program can be a
resource with which to teach patients, families, community organizations, and
surrogates about the process of informed consent and about genetic and
genomics research.
Conclusions
Genetic and genomics research is essential for the future of health care. Yet
this important research cannot be conducted without a balance between the
research mandate and the protection of human rights. The current research was
supported by an extensive literature review that was written and accepted for
publication. The manuscript included the development of a three-step process for
obtaining informed consent from surrogates in the ICU for genetic and genomics
research. Also, an author-developed stewardship of genetic and genomics
research model was used as the framework for the current study. From this
foundation, the author-developed ICIS Education Program and the authordeveloped Posttest Instrument were created.
Significant findings of the current study were:
1. Overall, the understanding of the process of informed consent and the
knowledge of genetic and genomics research were statistically
significantly higher in the experimental group than in the control group.
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2. Understanding the process of informed consent and the knowledge of
genetic and genomics research was statistically significantly higher in nine
of the 14 Items on the Posttest Instrument.
3. There was moderate internal consistency reliability of the Posttest
Instrument.
4. Based on the study findings, the ICIS ICU Education Program was
feasible, useful, and effective. No recommendations were made to modify
the ICIS ICU Education Program. No recommendations were made to
modify the Sample Consent Form. A suggestion was made to review the
clarity to wording on the part of the Sample Consent Form addressing
compensation for harm.
5. Because the Sample Consent Form does not address Items 2, 3, 7, 9, and
11, the use of the ICIS ICU Education Program along with the Sample
Consent Form is recommended because the Sample Consent Form alone
does not address information related to surrogate informed consent, the
knowledge of genetic and genomics research, and the purpose of the
Institutional Review Board. Likewise, surrogates must know that they have
a right to all of the information they need to make a research decision and
that they have a responsibility to represent the patient in making research
decisions.
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Appendix A, Table 1
Essential Elements of Surrogate Informed Consent in Genomics Research
Element
1

2.

Includes

All benefits

Are there benefits to the participant?

associated with

Is surrogate aware that research rarely benefits participant

the study

(therapeutic misconception)?

Genetic and

Is the surrogate aware of the ethical, legal, and social

Genomics

implications of genetic and genomics research

Research and

(stigmatization, emotional and psychological trauma,

ELSI

prospective consent issues, employment, adoption,

considerations

insurability, conflicts of interest, and commercialization of
donated human biological material, equipoise)?

3.

4.

Role of the

Is the surrogate aware that they may be asked to consent for

surrogate

a loved-one to participate in research?

Participation can

Is surrogate aware that consent can be withdrawn any time?

be withdrawn

Is the surrogate aware recent legal opinions may prevent
specimens already collected from being destroyed?

5.

6.

7.

Loved one is

Is the study experimental or not?

being asked to

What procedures may be needed?

participate in

What is the purpose of the study?

research

What is the duration of the study?

Risks associated

What are the anticipated or potential risks?

with the study

Are the risks minimal or substantial?

Human research

Is the surrogate aware of the Federal Common Rule?

protections

Is the surrogate aware of the IRB?
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8.

9.
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Contact

Is investigator contact information available to the surrogate

information

prior to and during the study?

Right to have

Is the surrogate aware of the right to have sufficient

sufficient

information to make a research decision?

information

Has surrogate understanding of the information given been
evaluated prior to obtaining consent?

10

Voluntary study

Is the surrogate aware that participation is voluntary?

11.

Alternative

Are there additional or alternative treatment options?

treatments

Is there Equipoise?

Confidentiality,

What are the study’s privacy and confidentiality policies?

privacy and

Can health information concerning the participant’s family be

12.

13.

14

•
•
•
•

ownership and

shared with them without the participant’s consent?

security of stored

Is ownership of human biological specimens clear?

specimens

Are stored specimens or information identifiable?

Compensation

Are the policies concerning whether compensation is

availability if

available, for harm that may come to a participant related to

participant

a research study, clearly articulated prior to consent in

harmed

studies involving more than minimal risk?

Substituted

Is the surrogate aware of the obligation to make research

judgment

decisions based on what the loved-one would want?

Source Elements 1,4,5,6,8,9,10,11,12,and 13: Source Elements 1-8, 11: U.S. Department of Health and Human
Services. 45 Code of Federal Regulations 46. 1991. Available at:
http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm. Accessed April 8, 2006.
Source Element 2 U.S. Department of Energy. Genomics and its impact on science and society: The Human
Genome Project and Beyond. 2005. Available at: http://DOEgenomes.org. Accessed January 18, 2006.
Source Element 12: Jeffers BE. Human biological material in research: ethical issues and the role of stewardship in
minimizing research risks. Adv Nurs Sci 2001;24(2):32-46.
Source Element 3 and 14 Coppolino, M., & Ackerson, L. (2001). Do surrogate decision makers provide accurate
consent for intensive care research? Chest, 119, 603-612.
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Appendix A, Table 2
Content Analysis of Essential Elements of Informed Consent in Genetic and
Genomics Research in the ICU With Corresponding ICIS ICU Education
Program Slides

Item

Essential Element

Slides

1

All benefits of research must be explained.

8, 11, 21, 34, 36

2

Genetic and genomic information

20-29, 31, 32, 36

3

Role of the surrogate

5, 15

4

May withdraw from study at any time

16, 21, 35

5

Research, purpose, and duration.

4, 6, 8, 21, 34

6

All research risks must be explained.

9, 10, 21

7

Human Research Protections

17

8

Contact information for researcher given

13, 21, 36

9

Right to sufficient information.

6, 7, 14, 16, 20,
34, 35

10

Research is voluntary

19, 21, 33, 34

11

Substituted judgment

15

12

Disclose privacy and confidentiality policy

29, 30, 35

13

Compensation for harm

11, 21, 34

14

Treatment alternatives must be described

12, 21, 34
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Appendix A, Table 3
Characteristics of the Sample
Experimental
Category

Characteristic

Frequency

%

Control
Frequency

%

Exact p
0.871

Age

Gender

Fisher’s

Male

20

14.9

25

18.7

Female

45

33.6

44

32.8

African American

15

11.2

18

13.4

Caucasian

50

37.3

50

37.3

Hispanic

0

0

1

8

Less than high

2

1.5

1

8

0.503

Race

Education

0.608

school

Relationship to

0.562

High school

15

11.2

19

14.2

Some college

23

17.2

24

17.9

College

22

16.4

18

13.4

Postgraduate

3

2.2

7

5.2

Spouse

10

7.5

10

7.5
0.265

the patient
Fiancée

0

0

3

2.2
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Significant other

1

0.8

2

1.5

Parent

13

9.7

7

5.2

Sibling

5

3.7

13

9.7

Child

12

9

13

9.7

Friend

2

1.5

2

1.5

Other

22

16.4

19

14.2
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Appendix A, Table 4
Characteristics of Participants With Missing Data Points
Characteristics of participants
Participant

Item

Group

Age

Gender

Race

Education

24

13

Experimental

41

Female

Caucasian

College

African-

High

45

2, 4

Control

67

Male
American

School

African-

Some

American

college

57

3

Control

37

Male
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Appendix A, Table 5
Non-parametric Analysis of Differences In Posttest Instrument Scores, Between
Groups By Item
Experimental
Item

Control

Mean

Median

SD

Mean

Median

SD

Wilcoxon p

1

4.7

5.0

0.74

4.2

5.0

1.18

0.015

2

4.5

5.0

0.85

3.9

4.0

1.08

0.000

3

4.8

5.0

0.53

3.7

4.0

1.37

0.000

4

4.9

5.0

0.56

4.4

5.0

1.26

0.002

5

4.7

5.0

0.76

4.6

5.0

0.84

0.362

6

4.9

5.0

0.27

4.7

5.0

0.90

0.117

7

4.7

5.0

0.63

4.2

5.0

097

0.001

8

4.9

5.0

0.45

4.7

5.0

0.57

0.034

9

4.9

5.0

0.45

4.8

5.0

0.55

0.079

10

5.0

5.0

0.28

4.9

5.0

0.29

0.710

11

4.7

5.0

0.61

4.1

4.0

1.17

0.000

12

4.9

5.0

0.27

4.9

5.0

0.34

0.317

13

4.6

5.0

0.90

4.1

5.0

1.34

0.005

14

4.6

5.0

0.98

4.0

4.0

1.22

0.001
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Appendix A, Table 6
Percent and Chi-Square Results for Participants Selecting the Most Correct
Answer (5) by Group (Top Box)
Experimental

Control

Item

%

%

Chi-square p

1

74

55

0.024

2

68

35

0.000

3

86

38

0.000

4

95

75

0.001

5

85

78

0.345

6

92

84

0.141

7

80

54

0.001

8

91

77

0.029

9

91

80

0.073

10

97

96

1.000

11

78

48

0.000

12

92

87

0.312

13

80

58

0.006

14

80

49

0.000
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Appendix A, Table 7
Responses to the Script Question
Response
“If I said OK to this, can I pick what I would let you do? Can I say it is OK
to take blood, but not do other things?”
“You all should know that you can’t take up this much of my time with
this stuff! Just tell me what I need to know and be done with it, and
don’t call me up in the middle of the night to give permission for
something, cause I won’t give it! I’m here all day and nobody asks me
nothing…”
“They should change those cartoons, they insult my intelligence.”
“I think everything is pretty clear…”
“How do I know if my husband is on this study now?”
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Appendix A, Table 8
Reasons Expressed by Visitors in the ICU Waiting Room for Non-participation
Reason
Visitors stated that they were summoned to the hospital at night and were fatigued
and had difficultly thinking.
Visitors stated that they were overwhelmed with fear and grief and could not deal
with anything else.
Visitors stated that research was a low priority for them.
Visitors stated that they did not want to leave their space in the ICU waiting room to
participate in the study for fear that they would lose “their corner”. Other resources
that visitors wanted to protect were recliners, tables, blankets, pillows, and
proximity (or distance) from the television.
Visitors stated that they could not leave personal belongings unattended if other
family members were not present, and were not willing to leave family members
to participate in the research if family members were present. Personal
belongings included computers, and bags with medications, food, and toiletries.
Visitors stated that their privacy was being invaded. Visitors stated that they thought
they were being approached by a staff member to talk about their loved-one and
were disappointed to realize that they were being asked to participate in research
instead. Some visitors verbalized that being approached in their personal “refuge”
was inconsiderate.
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Appendix A, Table 9
Table of Essential Elements of Informed Consent (1-14) Reflected in Posttest Items (1-14), Where Essential Elements
of Informed Consent are Covered, and Outcomes

Essential Element and
its Respective Posttest
Item (1-14)

Covered
in ICIS

Covered
in
SCF

ICIS plus SCF
effective above
and beyond
SCF alone and
SCF provides
information on
certain items

1. Research is intended
to benefit patients in the
future. It may not help
your loved-one.
2. Genomics studies
heredity and the
environment to answer
important health
questions.
3. A loved-one may be
too ill to agree to
participate in research.
When that happens,
you may be asked to

5 slides

x

x

ICIS plus
SCF not
effective
above and
beyond SCF
alone and
SCF
provides
information
on certain
items

ICIS plus
SCF
superior to
SCF alone
and SCF
provides no
information
on certain
items

3 slides

x

1 slides

x

ICIS plus SCF
superior to
SCF alone
and SCF
provides no
information on
certain items
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give permission for your
loved-one.
4. If you agree to
participate in research,
you may not withdraw
from the study until it is
finished.
5. You have the right to
know the purpose of the
study and how long it
will last.
6. Research risks your
loved-one might face
must be explained to
you.
7. The Institutional
Review Board approves
research. Part of their
job is to help protect
research participants.
8. The researchers will
make sure you know
how to contact them if
you wish to ask more
questions.
9. The researcher must
give you all the
information you need to
make an informed
decision about
research.

3 slides

x

x

5 slides

x

x

3 slides

x

x

1 slide

3 slides

7 slides

x

x

x

x
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10. Participating in
research is voluntary.
11. You should decide
whether to allow a
loved-one to participate
in research based on
what your loved-one
would want.
12. You have the right
to know if the
researcher plans to
keep your loved-one’s
personal information
confidential.
13. The informed
consent process
includes providing
information about
compensation for harm
that may come to your
loved-one during
research.
14. Some research
involves a treatment.
You must be told if
there are other
treatments you may
choose instead.

4 slides

x

x

1 slide

x

3 slides

x

x

3 slides

x

x

3 slides

x

x

Note: ICIS = ICIS ICU Education Program. SCF = Sample Consent Form.
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Appendix B, Figure 1
Jeffers Emerging Model of Research Risk
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Appendix B, Figure 2
Stewardship Model of Genetic and Genomics Research

Stewardship
of Genetic
and Genomics
Research
Research Mandate

Human Rights

Individual
Rights

Responsibility

Trust

Accountability

Family
Rights

Community
Rights
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Appendix B, Figure 3
Instrument: ICIS ICU Education Program Posttest

1.
2.
3.

4.
5.
6.
7.
8.
9.
10.
11.
12.
13.

14.

Research is intended to benefit patients in the
future. It may not help your loved-one.
Genomics studies heredity and the
environment to answer important health
questions.
A loved-one may be too ill to agree to
participate in research. When that happens,
you may be asked to give permission for your
loved-one.
If you agree to participate in research, you
may
not withdraw from the study until it is finished.
You have the right to know the purpose of the
study and how long it will last.
Research risks your loved-one might face
must be explained to you.
The Institutional Review Board approves
research. Part of their job is to help protect
research participants.
The researchers will make sure you know
how to contact them if you wish to ask more
questions.
The researcher must give you all the
information you need to make an informed
decision about research.
Participating in research is voluntary.
You should decide whether to allow a lovedone to participate in research based on what
your loved-one would want.
You have the right to know if the researcher
plans to keep your loved-one’s personal
information confidential.
The informed consent process includes
providing information about compensation for
harm that may come to your loved-one during
research.
Some research involves a treatment. You
must be told if there are other treatments you
may choose instead.

Definitely
False

Probably
False

Unsure

Probably
True

Statement

Definitely
True

For each statement, please place an “X” in the correct column.
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Appendix B, Figure 4
Demographic Data Form
Thank you for taking the time to complete this survey. Please select the answer that
most pertains to you.
1. What is your
gender?
What is your age (in
2. years)?

3.

Male

Female

________
African-American

Asian

Caucasian

Hispanic

Other_________________

What is your race?

What is your
4. occupation?

What is your
relationship to the
5. patient? (check
one)

______________________________________________
Spouse

Fiancé

Significant Other

Parent

Child

Brother/Sister

Friend

Other______________________
Less than High School
High School or GED

What is the highest
grade you
6. completed in
school?

Some College or Associates Degree
College Graduate
Post Graduate

Have you ever
participated in
7.
medical research?
7a. If you
answered “yes” to
number 7,
did you feel that you
had enough
information to make
a decision?

Yes

Yes

No

No
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Appendix B, Figure 5
IRB Approval from Washington University
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Appendix B, Table 6
University of Missouri – St. Louis IRB Approval Letter
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